Single-Manager Hedge Funds: The Best Way to Get a Recurring Guest Spot on CNBC?
Mergers and Inquisitions
JANUARY 31, 2024
In-depth analysis that might take days or weeks, such as a financial model with 1,000 rows in Excel to assess a biopharma company’s valuation. You still pay attention to catalysts and investor sentiment, but the job is more about forming a long-term view of asset prices – not predicting what will happen on the earnings call next week.
Let's personalize your content